Similar articles

• Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy.

  Divgi C, Carrasquillo JA, Meredith R, Seo Y, Frey EC, Bolch WE, Zimmerman BE, Akabani G, Jacobson DA, Brown B, Davern SM, Hobbs RF, Humm J, Moros EG, Morse D, Papineni R, Zanzonico P, Benedict SH, Sgouros G. Divgi C, et al. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):905-912. doi: 10.1016/j.ijrobp.2020.12.002. Epub 2020 Dec 10. Int J Radiat Oncol Biol Phys. 2021. PMID: 33309909 Free PMC article. Review.
• Activity quantification and dosimetry in radiopharmaceutical therapy with reference to ¹⁷⁷Lutetium.

  Ramonaheng K, Qebetu M, Ndlovu H, Swanepoel C, Smith L, Mdanda S, Mdlophane A, Sathekge M. Ramonaheng K, et al. Front Nucl Med. 2024 Mar 28;4:1355912. doi: 10.3389/fnume.2024.1355912. eCollection 2024. Front Nucl Med. 2024. PMID: 39355215 Free PMC article. Review.
• Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer.

  Beauregard JM. Beauregard JM. Cancer Imaging. 2022 Dec 9;22(1):67. doi: 10.1186/s40644-022-00505-y. Cancer Imaging. 2022. PMID: 36494731 Free PMC article. Review.
• Dosimetry for Radiopharmaceutical Therapy: Practical Implementation, From the AJR Special Series on Quantitative Imaging.

  Zanzonico P. Zanzonico P. AJR Am J Roentgenol. 2025 Jan 8. doi: 10.2214/AJR.24.31873. Online ahead of print. AJR Am J Roentgenol. 2025. PMID: 39772581 Review.
• Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities.

  Graves SA, Bageac A, Crowley JR, Merlino DAM. Graves SA, et al. J Nucl Med. 2021 Dec;62(Suppl 3):48S-59S. doi: 10.2967/jnumed.121.262752. J Nucl Med. 2021. PMID: 34857622